These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9807208)

  • 21. Management of locally advanced breast cancer. Mini-review.
    Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
    Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer].
    Souchon R; Dunst J; Hartmann KA
    Strahlenther Onkol; 2006 Apr; 182(4):202-9. PubMed ID: 16622621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?
    Ring A; Webb A; Ashley S; Allum WH; Ebbs S; Gui G; Sacks NP; Walsh G; Smith IE
    J Clin Oncol; 2003 Dec; 21(24):4540-5. PubMed ID: 14673041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant chemotherapy with anthracyclines in comparison with the standard combination of CMF in breast cancer with high risk of relapse].
    Semiglazov VF; Bozhok AA; Ivanova OA; Ivanov VG; Arzumanov AS; Barash NIu; Orlov AA; Golubëva OM; Topuzov EE; Seleznev IK; Migmanova NSh; Popova PT; Brezhneva TV; Paltuev RM
    Vopr Onkol; 2000; 46(2):160-6. PubMed ID: 10853413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
    ; Basser RL; O'Neill A; Martinelli G; Green MD; Peccatori F; Cinieri S; Coates AS; Gelber RD; Aebi S; Castiglione-Gertsch M; Viale G; Price KN; Goldhirsch A
    J Clin Oncol; 2006 Jan; 24(3):370-8. PubMed ID: 16421418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
    J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
    Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
    Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
    Oh JL; Dryden MJ; Woodward WA; Yu TK; Tereffe W; Strom EA; Perkins GH; Middleton L; Hunt KK; Giordano SH; Oswald MJ; Domain D; Buchholz TA
    J Clin Oncol; 2006 Nov; 24(31):4971-5. PubMed ID: 17075114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
    Kim R; Osaki A; Tanabe K; Toge T
    Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission.
    Blohmer JU; Paepke S; Kissner L; Elling D; Fleige B; Grineisen Y; Lichtenegger W
    Zentralbl Gynakol; 1999; 121(11):522-5. PubMed ID: 10612219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some prognostic factors in the combined therapy of locally advanced breast cancer].
    Voznyĭ EK; Kharchenko VP; Gurov SN; Dobrovol'skaia NIu; Bol'shakova SA
    Vopr Onkol; 2000; 46(6):732-6. PubMed ID: 11219949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.